SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019714
Filing Date
2023-05-09
Accepted
2023-05-09 16:20:17
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dsgn-20230331.htm   iXBRL 10-Q 2308431
2 EX-31.1 dsgn-ex31_1.htm EX-31 22763
3 EX-32.1 dsgn-ex32_1.htm EX-32 15115
  Complete submission text file 0000950170-23-019714.txt   7674056

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dsgn-20230331.xsd EX-101.SCH 41108
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dsgn-20230331_lab.xml EX-101.LAB 319344
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dsgn-20230331_cal.xml EX-101.CAL 36256
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dsgn-20230331_pre.xml EX-101.PRE 226280
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dsgn-20230331_def.xml EX-101.DEF 116217
56 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20230331_htm.xml XML 1582161
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 23902359
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences